Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ

Modern Pathology, Published online: 07 June 2019; doi:10.1038/s41379-019-0286-9Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ
Source: Modern Pathology - Category: Pathology Authors: Source Type: research

Related Links:

ConclusionsMRI is the best predictor of tumor size in breast cancer. Histologic type and tumor size are key parameters when estimating tumor size and should be taken into account when planning surgery. Patient age does not interfere with the interpretation of imaging tests.ResumenIntroducciónEl objetivo de este estudio fue evaluar qué prueba de imagen de las empleadas para medir el tamaño del cáncer de mama primario preoperatorio (mamografía, ecografía o resonancia magnética (RM)) se correlacionó mejor con el tamaño del tumor en la pieza quirúrgica posto...
Source: Cirugia Espanola - Category: Surgery Source Type: research
Abstract BACKGROUND: This randomized controlled trial aimed to investigate the effects of circumferential shaving on reducing the intraoperative margin positivity rate (MPR) during breast-conserving surgery (BCS). METHODS: Eligible breast cancer patients were randomly assigned into no-shave and shave groups. In the no-shave group, the cavity margins were collected for assessment after the tumor resection, whereas in the shave group, a circumferential shaving was performed before collecting the cavity margins. The primary outcome was the intraoperative MPR by frozen section analysis. RESULTS: A total of 1...
Source: Ann Oncol - Category: Cancer & Oncology Authors: Tags: Ann Surg Oncol Source Type: research
Breast conserving surgery (BCS) followed by radiation therapy (RT) is the primary management for many women with early-stage, invasive breast cancer and ductal carcinoma in situ (DCIS) [1 –4]. Most women achieve good to excellent cosmesis after BCS and RT but some experience cosmetic failure, defined as fair or poor cosmetic outcomes [5–17]. However, comparisons of cosmetic outcomes across international jurisdictions using contemporary surgical and RT techniques for DCIS are lack ing.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research
FRIDAY, Aug. 16, 2019 -- An artificial intelligence program outperforms pathologists for differentiating ductal carcinoma in situ (DCIS) from atypia, according to a study published online Aug. 9 in JAMA Network Open. Ezgi Mercan, Ph.D., from the...
Source: - Pharma News - Category: Pharmaceuticals Source Type: news
Conclusions: The ADC-min values are significantly different among IDC, IDC-DCIS, and DCIS, with the lowest ADC-min values in IDC, followed by IDC-DCIS and DCIS. The ADC-min maybe used as a promising parameter to differentiate DCIS and invasive cancer.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research
In conclusion, the presence of calcifications and vascularity on sonography or a lager distribution of calcifications on mammography may suggest DCISM. PMID: 31396390 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Mol Clin Oncol Source Type: research
UCLA researchers have developed an artificial intelligence system that could help pathologists read biopsies more accurately and to better detect and diagnose breast cancer.The new system,described in a study published today in JAMA Network Open, helps interpret medical images used to diagnose breast cancer that can be difficult for the human eye to classify, and it does so nearly as accurately or better as experienced pathologists.“It is critical to get a correct diagnosis from the beginning so that we can guide patients to the most effective treatments,” said Dr. Joann Elmore, the study’s senior author ...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Conclusion: The results of this study with a long follow-up period have shown that ART in DCIS is an effective treatment method to provide local disease control. However, further large studies are needed to identify the prognostic factors. PMID: 31382732 [PubMed - as supplied by publisher]
Source: Turkish Journal of Medical Sciences - Category: General Medicine Tags: Turk J Med Sci Source Type: research
Condition:   Breast Ductal Carcinoma in Situ Interventions:   Drug: Low-dose tamoxifen;   Radiation: Whole breast radiotherapy Sponsors:   National Taiwan University Hospital;   Tri-Service General Hospital;   Koo Foundation Sun Yat-Sen Cancer Center;   Kaohsiung Medical University;   Kyoto University;   Mackay Memorial Hospital Recruiting
Source: - Category: Research Source Type: clinical trials
In 13 –50%, Ductal Carcinoma In Situ (DCIS) progresses to an Invasive Ductal Carcinoma (IDC). As the individual progression risk from DCIS to IDC cannot be estimated based on clinical parameters or biomarkers, all patients with DCIS are medically treated equally. However, the role of tumor microenvironm ent and especially of tumor-associated fibroblasts (TAFs) appears to be critical for progression from DCIS to IDC. Based on previous work by Sameni et al. (2012), the aim of this study was to establish a 3D co-culture of primary fibroblasts and DCIS cells in vitro as a model for further investigatio ns of TAFs’ ...
Source: Maturitas - Category: Primary Care Authors: Tags: LBO03 Source Type: research
More News: Breast Carcinoma | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Pathology